Amedisys Inc (AMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Amedisys Inc (AMED) has a cash flow conversion efficiency ratio of 0.053x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($67.21 Million) by net assets ($1.27 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Amedisys Inc for the company's overall valuation and market capitalisation.
Amedisys Inc - Cash Flow Conversion Efficiency Trend (1994–2024)
This chart illustrates how Amedisys Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Amedisys Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amedisys Inc ranked by their cash flow conversion efficiency. Explore AMED cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Luxi Chemical Group Co Ltd
SHE:000830
|
0.041x |
|
Kunshan Kinglai Hygienic Materials Co Ltd
SHE:300260
|
0.016x |
|
Catcher Technology Co Ltd
TW:2474
|
0.011x |
|
SSAB AB (publ)
ST:SSAB-A
|
0.005x |
|
Lotus Health Group Co
SHG:600186
|
0.046x |
|
China Zhenhua Group Science & Technology Co Ltd
SHE:000733
|
-0.018x |
|
Jiangxi Jovo Energy Co. Ltd
SHG:605090
|
-0.003x |
|
Krishna Institute of Medical Sciences Limited
NSE:KIMS
|
0.111x |
Annual Cash Flow Conversion Efficiency for Amedisys Inc (1994–2024)
The table below shows the annual cash flow conversion efficiency of Amedisys Inc from 1994 to 2024. View AMED stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.18 Billion | $221.66 Million | 0.188x | +53.34% |
| 2023-12-31 | $1.12 Billion | $137.19 Million | 0.123x | +1.72% |
| 2022-12-31 | $1.11 Billion | $133.28 Million | 0.120x | -37.75% |
| 2021-12-31 | $976.32 Million | $188.89 Million | 0.193x | -45.72% |
| 2020-12-31 | $810.74 Million | $288.95 Million | 0.356x | +13.19% |
| 2019-12-31 | $641.51 Million | $202.00 Million | 0.315x | -32.00% |
| 2018-12-31 | $482.63 Million | $223.48 Million | 0.463x | +126.17% |
| 2017-12-31 | $516.43 Million | $105.73 Million | 0.205x | +51.64% |
| 2016-12-31 | $461.14 Million | $62.26 Million | 0.135x | -48.59% |
| 2015-12-31 | $410.44 Million | $107.78 Million | 0.263x | +259.39% |
| 2014-12-31 | $397.76 Million | $-65.53 Million | -0.165x | -160.01% |
| 2013-12-31 | $372.48 Million | $102.26 Million | 0.275x | +79.45% |
| 2012-12-31 | $454.23 Million | $69.49 Million | 0.153x | -43.83% |
| 2011-12-31 | $520.15 Million | $141.66 Million | 0.272x | +16.15% |
| 2010-12-31 | $879.72 Million | $206.27 Million | 0.234x | -30.29% |
| 2009-12-31 | $736.34 Million | $247.66 Million | 0.336x | +25.42% |
| 2008-12-31 | $562.12 Million | $150.74 Million | 0.268x | +29.01% |
| 2007-12-31 | $447.82 Million | $93.08 Million | 0.208x | +75.63% |
| 2006-12-31 | $364.01 Million | $43.08 Million | 0.118x | -47.65% |
| 2005-12-31 | $192.60 Million | $43.54 Million | 0.226x | +12.97% |
| 2004-12-31 | $148.47 Million | $29.71 Million | 0.200x | -52.79% |
| 2003-12-31 | $51.40 Million | $21.79 Million | 0.424x | -35.33% |
| 2002-12-31 | $16.96 Million | $11.12 Million | 0.655x | -71.14% |
| 2001-12-31 | $3.37 Million | $7.66 Million | 2.271x | +163.06% |
| 2000-12-31 | $-1.92 Million | $6.91 Million | -3.601x | -496.48% |
| 1999-12-31 | $-10.10 Million | $-9.18 Million | 0.908x | +237.93% |
| 1998-12-31 | $-11.58 Million | $7.63 Million | -0.658x | -377.44% |
| 1997-12-31 | $8.28 Million | $-1.14 Million | -0.138x | +33.56% |
| 1996-12-31 | $4.50 Million | $-934.84K | -0.208x | -155.79% |
| 1995-12-31 | $4.30 Million | $1.60 Million | 0.372x | +181.86% |
| 1994-12-31 | $2.20 Million | $-1.00 Million | -0.455x | -- |
About Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more